Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 18:1_20:1_24:5)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003326 AN005449 Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism Liver Mouse Liver disease University of Melbourne LC-MS
  logo